Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design.
Brookhart MA, Mayne TJ, Coombs C, Breskin A, Ness E, Bessonova L, Chu YJ, Li J, Fried MW, Hansen BE, Kowdley KV, Jones D, Mells G, Trivedi PJ, Hiu S, Kareithi DN, Wason J, Smith R, Seeger JD, Hirschfield GM. Brookhart MA, et al. Among authors: hansen be. Hepatology. 2024 Dec 2. doi: 10.1097/HEP.0000000000001174. Online ahead of print. Hepatology. 2024. PMID: 39630028
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
Andrews TS, Nakib D, Perciani CT, Ma XZ, Liu L, Winter E, Camat D, Chung SW, Lumanto P, Manuel J, Mangroo S, Hansen B, Arpinder B, Thoeni C, Sayed B, Feld J, Gehring A, Gulamhusein A, Hirschfield GM, Ricciuto A, Bader GD, McGilvray ID, MacParland S. Andrews TS, et al. J Hepatol. 2024 May;80(5):730-743. doi: 10.1016/j.jhep.2023.12.023. Epub 2024 Jan 8. J Hepatol. 2024. PMID: 38199298 Free article.
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study.
de Veer RC, van Hooff MCB, Werner E, Beuers U, Drenth JPH, Cuperus FJC, van Hoek B, Veldt BJ, Klemt-Kropp M, van Meer S, Verdonk RC, Flink HJ, Vrolijk JM, Gevers TJG, Ponsioen CY, Ter Borg MJ, Soufidi K, Boersma F, de Jonge HJM, Wolfhagen FHJ, Baak LC, Onderwater SL, van Bergeijk JD, van Putten PG, de Bruin GJ, Adang RPR, Aparicio-Pages MN, de Boer W, Borg FT, van Soest H, Janssen HLA, Hansen BE, Erler NS, van der Meer AJ; Dutch PBC Study Group. de Veer RC, et al. Among authors: hansen be. JHEP Rep. 2024 Jun 6;6(8):101132. doi: 10.1016/j.jhepr.2024.101132. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39113899 Free PMC article.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Hirode G, Hansen BE, Chen CH, Su TH, Wong G, Seto WK, Van Hees S, Papatheodoridi M, Brakenhoff SM, Lens S, Choi HSJ, Chien RN, Feld JJ, Forns X, Sonneveld MJ, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Chan HLY, Kao JH, Hsu YC, Cornberg M, Jeng WJ, Janssen HLA; RETRACT-B study group. Hirode G, et al. Among authors: hansen be. Am J Gastroenterol. 2023 Sep 1;118(9):1601-1608. doi: 10.14309/ajg.0000000000002203. Epub 2023 Jan 30. Am J Gastroenterol. 2023. PMID: 36719174
Hepatobiliary cancers in South America: disparity strikes.
Debes JD, Boonstra A, Balderramo D, Mattos AZ, Arrese M; ESCALON investigators. Debes JD, et al. Lancet Gastroenterol Hepatol. 2019 Aug;4(8):581. doi: 10.1016/S2468-1253(19)30188-8. Lancet Gastroenterol Hepatol. 2019. PMID: 31292069 No abstract available.
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study).
Dongelmans EJ, Hirode G, Hansen BE, Chen CH, Su TH, Seto WK, Furquim d'Almeida A, van Hees S, Papatheodoridi M, Lens S, Wong GLH, Brakenhoff SM, Chien RN, Feld JJ, Chan HLY, Forns X, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Hsu YC, Kao JH, Cornberg M, Sonneveld MJ, Jeng WJ, Janssen HLA; RETRACT-B study group. Dongelmans EJ, et al. Among authors: hansen be. J Hepatol. 2024 Aug 31:S0168-8278(24)02493-0. doi: 10.1016/j.jhep.2024.08.015. Online ahead of print. J Hepatol. 2024. PMID: 39773379
FVIII peptides presented on HLA-DP and identification of an A3 domain peptide binding with high affinity to the commonly expressed HLA-DP4.
Miranda M, Hansen BE, Wehbi B, Porcheddu V, Van Alphen FPJ, Kaijen P, Fijnvandraat K, Lacroix-Desmazes S, Van den Biggelaar M, Maillere B, Voorberg J; EDUC8 Consortium. Miranda M, et al. Among authors: hansen be. Haematologica. 2024 Dec 12. doi: 10.3324/haematol.2024.286204. Online ahead of print. Haematologica. 2024. PMID: 39665218 Free article.
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials.
Dongelmans EJ, Feld JJ, Boonstra A, Brakenhoff SM, Wong D, Yim C, Claassen M, Honkoop P, Hansen BE, de Man RA, Fung S, Berg T, van Bömmel F, Janssen HLA, Sonneveld MJ. Dongelmans EJ, et al. Among authors: hansen be. Aliment Pharmacol Ther. 2025 Feb;61(3):570-578. doi: 10.1111/apt.18416. Epub 2024 Dec 3. Aliment Pharmacol Ther. 2025. PMID: 39624922 Free PMC article.
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV, Hirschfield GM, Coombs C, Malecha ES, Bessonova L, Li J, Rathnayaka N, Mells G, Jones DE, Trivedi PJ, Hansen BE, Smith R, Wason J, Hiu S, Kareithi DN, Mason AL, Bowlus CL, Muller K, Carbone M, Berenguer M, Milkiewicz P, Adekunle F, Villamil A. Kowdley KV, et al. Among authors: hansen be. Am J Gastroenterol. 2025 Jan 1;120(1):263. doi: 10.14309/ajg.0000000000003153. Epub 2024 Nov 29. Am J Gastroenterol. 2025. PMID: 39621001 No abstract available.
399 results